Variant report

Variant	nsv975977
Chromosome Location	chr11:104971009-104972355
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr11:104970890-104971077	GM12878	blood:	n/a	n/a
2	CTCF	chr11:104971768-104971837	GM10266	blood:	n/a	n/a
3	FOS	chr11:104970835-104971425	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
4	FOS	chr11:104970836-104971491	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
5	FOS	chr11:104970870-104971415	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
6	FOS	chr11:104971940-104972376	MCF10A-Er-Src	breast:	n/a	n/a
7	FOS	chr11:104972012-104972419	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr11:104970925-104971329	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
9	FOS	chr11:104970874-104971326	HUVEC	blood vessel:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
10	FOS	chr11:104971878-104972346	MCF10A-Er-Src	breast:	n/a	chr11:104971936-104971945
11	FOS	chr11:104972042-104972303	MCF10A-Er-Src	breast:	n/a	n/a
12	GATA2	chr11:104970412-104971122	HUVEC	blood vessel:	n/a	chr11:104970654-104970665 chr11:104970652-104970661 chr11:104971022-104971032 chr11:104970575-104970585
13	JUND	chr11:104971147-104971315	H1-hESC	embryonic stem cell:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
14	MYC	chr11:104970915-104971322	MCF10A-Er-Src	breast:	n/a	n/a
15	MYC	chr11:104971795-104972416	MCF10A-Er-Src	breast:	n/a	n/a
16	MYC	chr11:104970971-104971322	MCF10A-Er-Src	breast:	n/a	n/a
17	MYC	chr11:104971999-104972414	MCF10A-Er-Src	breast:	n/a	n/a
18	POLR2A	chr11:104971978-104972500	MCF10A-Er-Src	breast:	n/a	n/a
19	POLR2A	chr11:104970868-104972388	MCF10A-Er-Src	breast:	n/a	n/a
20	POLR2A	chr11:104971071-104971566	MCF10A-Er-Src	breast:	n/a	n/a
21	STAT3	chr11:104972055-104972356	MCF10A-Er-Src	breast:	n/a	chr11:104972173-104972184
22	STAT3	chr11:104970921-104971275	MCF10A-Er-Src	breast:	n/a	chr11:104971221-104971230
23	STAT3	chr11:104971064-104971275	MCF10A-Er-Src	breast:	n/a	chr11:104971221-104971230
24	STAT3	chr11:104972085-104972366	MCF10A-Er-Src	breast:	n/a	chr11:104972173-104972184
25	STAT3	chr11:104972038-104972480	MCF10A-Er-Src	breast:	n/a	chr11:104972173-104972184
26	STAT3	chr11:104970907-104971325	MCF10A-Er-Src	breast:	n/a	chr11:104971221-104971230
27	STAT3	chr11:104970943-104971360	MCF10A-Er-Src	breast:	n/a	chr11:104971221-104971230
28	STAT3	chr11:104972036-104972353	MCF10A-Er-Src	breast:	n/a	chr11:104972173-104972184

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:104972135-104972185	BJ	skin:	n/a
2	chr11:104972135-104972185	Caco-2	colon:	n/a
3	chr11:104972135-104972185	GM06990	blood:	n/a
4	chr11:104972135-104972185	AG09309	skin:	n/a
5	chr11:104972078-104972128	HCPEpiC	choroid plexus:	n/a
6	chr11:104972078-104972128	NH-A	brain:	n/a
7	chr11:104972135-104972185	MCF10A-Er-Src	breast:	n/a
8	chr11:104972078-104972128	MCF10A-Er-Src	breast:	n/a
9	chr11:104972135-104972185	SK-N-SH	brain:	n/a
10	chr11:104972078-104972128	Jurkat	blood:	n/a
11	chr11:104972135-104972185	GM12891	blood:	n/a
12	chr11:104972078-104972128	HEEpiC	esophagus:	n/a
13	chr11:104972078-104972128	HMEC	breast:	n/a
14	chr11:104972078-104972128	SK-N-SH_RA	brain:	n/a
15	chr11:104972135-104972185	AG09319	gingival:	n/a
16	chr11:104972078-104972128	PFSK-1	brain:	n/a
17	chr11:104972078-104972128	HAEpiC	amniotic membrane:	n/a
18	chr11:104972135-104972185	Jurkat	blood:	n/a
19	chr11:104972078-104972128	SK-N-SH	brain:	n/a
20	chr11:104972135-104972185	SK-N-MC	brain:	n/a
21	chr11:104972135-104972185	HCF	heart:	n/a
22	chr11:104972135-104972185	PFSK-1	brain:	n/a
23	chr11:104972078-104972128	PANC-1	pancreas:	n/a
24	chr11:104972078-104972128	HIPEpiC	eye:	n/a
25	chr11:104972135-104972185	ProgFib	skin:	n/a
26	chr11:104972078-104972128	T-47D	breast:	n/a
27	chr11:104972078-104972128	GM19239	blood:	n/a
28	chr11:104972078-104972128	AG10803	skin:	n/a
29	chr11:104972078-104972128	K562	blood:	n/a
30	chr11:104972078-104972128	GM12892	blood:	n/a
31	chr11:104972135-104972185	NHDF-neo	bronchial:	n/a
32	chr11:104972078-104972128	HCT-116	colon:	n/a
33	chr11:104972078-104972128	HNPCEpiC	eye:	n/a
34	chr11:104972135-104972185	AG10803	skin:	n/a
35	chr11:104972078-104972128	H1-hESC	embryonic stem cell:	embryo
36	chr11:104972078-104972128	Hepatocyte	liver:	n/a
37	chr11:104972135-104972185	HCPEpiC	choroid plexus:	n/a
38	chr11:104972078-104972128	AG09309	skin:	n/a
39	chr11:104972078-104972128	AG09319	gingival:	n/a
40	chr11:104972135-104972185	Hepatocyte	liver:	n/a
41	chr11:104972135-104972185	MCF-7	breast:	n/a
42	chr11:104972078-104972128	CMK	blood:	n/a
43	chr11:104972078-104972128	RPTEC	kidney:	n/a
44	chr11:104972078-104972128	GM06990	blood:	n/a
45	chr11:104972078-104972128	AoSMC	blood vessel:	n/a
46	chr11:104972135-104972185	BE2_C	brain:	n/a
47	chr11:104972135-104972185	HRCEpiC	kidney:	n/a
48	chr11:104972078-104972128	NHBE	bronchial:	n/a
49	chr11:104972078-104972128	ovcar-3	ovarian:	n/a
50	chr11:104972078-104972128	Hela-S3	cervix:	n/a

Variant related genes	Relation type
CASP1	TF binding region
CARD17	TF binding region
CARD16	TF binding region
CASP1	CpG island
CARD17	CpG island
CARD16	CpG island

Extended variants
information (count: 99 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:99 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549323651	chr11:104971032-104971033	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs183519068	chr11:104971064-104971065	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs551631083	chr11:104971075-104971076	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs528363577	chr11:104971082-104971083	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs144853764	chr11:104971093-104971094	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs571455509	chr11:104971136-104971137	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs188059376	chr11:104971137-104971138	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs148591074	chr11:104971166-104971167	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs368957743	chr11:104971199-104971200	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs1792771	chr11:104971210-104971211	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs200253979	chr11:104971211-104971212	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs375954576	chr11:104971213-104971214	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs116219126	chr11:104971219-104971220	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs552912050	chr11:104971221-104971222	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs369535290	chr11:104971230-104971231	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs34491690	chr11:104971233-104971234	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs12806837	chr11:104971257-104971258	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs142170489	chr11:104971259-104971260	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs377360333	chr11:104971268-104971269	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs147785095	chr11:104971298-104971299	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs141250558	chr11:104971309-104971310	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs563646714	chr11:104971325-104971326	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs146921776	chr11:104971329-104971330	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs371882308	chr11:104971354-104971355	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs115239439	chr11:104971362-104971363	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs147300962	chr11:104971389-104971390	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs559681964	chr11:104971391-104971392	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs182015339	chr11:104971395-104971396	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs186252477	chr11:104971397-104971398	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs140871607	chr11:104971431-104971432	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs138350235	chr11:104971452-104971453	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs145180818	chr11:104971459-104971460	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs199641565	chr11:104971460-104971461	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs200199103	chr11:104971470-104971471	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs190009513	chr11:104971482-104971483	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs567278726	chr11:104971483-104971484	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs536330716	chr11:104971487-104971488	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs536089974	chr11:104971492-104971493	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs149604423	chr11:104971495-104971496	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs376627579	chr11:104971505-104971506	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs111274235	chr11:104971507-104971508	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs370266736	chr11:104971518-104971519	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs375024129	chr11:104971523-104971524	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs199978542	chr11:104971535-104971536	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs372222869	chr11:104971546-104971547	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs374186187	chr11:104971547-104971548	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs538199737	chr11:104971555-104971556	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs397833573	chr11:104971565-104971566	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs74329143	chr11:104971576-104971577	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs181643718	chr11:104971618-104971619	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Melanoma	17363583	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Obesity	19966786	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:104964400-104971600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr11:104969600-104972200	Enhancers	NHEK	skin
3	chr11:104970000-104974200	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr11:104970200-104971400	Enhancers	Dnd41	blood
5	chr11:104970200-104972200	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr11:104970200-104972200	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
7	chr11:104970400-104971600	Enhancers	HUVEC	blood vessel
8	chr11:104970400-104972200	Enhancers	Primary hematopoietic stem cells	blood
9	chr11:104970400-104972200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr11:104970400-104972400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr11:104970400-104972600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
12	chr11:104970600-104972000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr11:104970600-104972200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
14	chr11:104970600-104972200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
15	chr11:104970800-104971200	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr11:104970800-104971200	Enhancers	Primary T cells from cord blood	blood
17	chr11:104970800-104971600	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
18	chr11:104970800-104971800	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
19	chr11:104970800-104972000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
20	chr11:104970800-104972200	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
21	chr11:104970800-104972400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
22	chr11:104971000-104971200	Active TSS	Primary T regulatory cells fromperipheralblood	blood
23	chr11:104971000-104971400	Enhancers	H1 Cell Line	embryonic stem cell
24	chr11:104971000-104971400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr11:104971000-104971400	Flanking Active TSS	Primary T cells fromperipheralblood	blood
26	chr11:104971000-104971400	Active TSS	Primary T killer memory cells from peripheral blood	blood
27	chr11:104971000-104971600	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr11:104971000-104971800	Enhancers	HMEC	breast
29	chr11:104971000-104972000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr11:104971000-104972200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
31	chr11:104971000-104972200	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
32	chr11:104971000-104972200	Enhancers	Adipose Nuclei	Adipose
33	chr11:104971000-104972200	Enhancers	Placenta	Placenta
34	chr11:104971000-104972400	Active TSS	Duodenum Mucosa	Duodenum
35	chr11:104971200-104971400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr11:104971200-104971400	Enhancers	Esophagus	oesophagus
37	chr11:104971200-104972000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr11:104971200-104972400	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
39	chr11:104971400-104972000	Enhancers	Primary T killer memory cells from peripheral blood	blood
40	chr11:104971400-104972200	Active TSS	Primary T cells fromperipheralblood	blood
41	chr11:104971600-104972400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr11:104971600-104972400	Enhancers	Breast Myoepithelial Primary Cells	Breast
43	chr11:104971600-104972400	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
44	chr11:104971800-104972200	Active TSS	Primary T helper naive cells from peripheral blood	blood
45	chr11:104972000-104972200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
46	chr11:104972000-104972200	Enhancers	Esophagus	oesophagus
47	chr11:104972200-104972400	Enhancers	Primary T helper cells PMA-I stimulated	--
48	chr11:104972200-104972400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
49	chr11:104972200-104972400	Enhancers	Primary T helper cells fromperipheralblood	blood
50	chr11:104972200-104972600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links